Physician profile
Curtis L Cetrulo
NPI 1801084462
$8,766.08
in general payments reported to CMS, 2019-2025
13 companies · $3,825 in 2025
The $3,825 reported for 2025 was more than what 91% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $24.69 · 2021: $718 · 2022: $1,490 · 2023: $536 · 2024: $2,014 · 2025: $3,825.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,477 · Travel and Lodging: $1,398 · Consulting Fee: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,477.24 |
| Travel and Lodging | $1,398.32 |
| Consulting Fee | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $5,990.31 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Integra Lifesciences Corporation | $887.86 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Rti Surgical, INC | $506.08 | 2025 | |
| Axogen | $360.51 | 2024 | Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector, Axoguard Nerve Protector |
| Biocircuit Technologies INC | $260.77 | 2025 | Nerve Tape |
| Becton, Dickinson and Company | $185.20 | 2025 | Phasix Mesh |
| Medical Microinstruments, INC. | $156.31 | 2024 | Symani Surgical Systems |
| Derma Sciences, INC. | $136.09 | 2019 | |
| Mentor Worldwide LLC | $117.05 | 2019-2021 | |
| Innovation Technologies INC | $100.08 | 2022 | |
| Davol INC. | $41.13 | 2024 | Phasix Mesh |
| Smith+Nephew, INC. | $24.69 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Curtis Cetrulo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.